[Arterial hypertension and cardiovascular risk: need for a combined strategy of intervention]

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Pharmacology

Background:

• Arterial hypertension is a prevalent condition linked to elevated cardiovascular risk.
• Current treatment emphasizes blood pressure control and drugs with pleiotropic effects.
• Understanding hypertension's pathogenesis is key to improved prevention and treatment strategies.

Purpose of the Study:

• To explore the role of Angiotensin II in hypertension-induced vascular inflammation.
• To investigate the interplay between Angiotensin II, oxidative stress, and endothelial dysfunction.
• To identify potential targets for an integrated therapeutic approach in hypertensive patients.

Main Methods:

• Review of current evidence on the pathogenetic mechanisms of arterial hypertension.
• Analysis of the role of Angiotensin II in triggering vascular inflammation and oxidative stress.
• Examination of the link between oxidative stress, pro-inflammatory mediators, and endothelial dysfunction.

Main Results:

• Angiotensin II appears to initiate vascular inflammation via oxidative stress.
• This process leads to the upregulation of pro-inflammatory mediators.
• Endothelial dysfunction and vascular injury are consequences of this inflammatory cascade.

Conclusions:

• The interaction between Angiotensin II, oxidative stress, and endothelial dysfunction is central to hypertension's vascular pathology.
• This pathway presents a promising target for novel, integrated therapeutic strategies.
• Such an approach holds significant potential for improving clinical outcomes in hypertensive individuals.